EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sarcopenia in Colorectal Cancer Surgery—Minimally Invasive vs. Open

Felix Merboth iD, Miriam Müller-Oerlinghausen, Heiner Nebelung, Andreas Bogner, Mathieu Pecqueux, Nadja Salisch, Marius Distler, Verena Plodeck, Ralf-Thorsten Hoffmann, Johannes Fritzmann, Jürgen Weitz, Johanna Kirchberg

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.70065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Felix Merboth und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Thoracic and Vascular Surgery, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden,…. Hauptthemen laut MEDLINE: Sarcopenia, Colorectal Neoplasms, Minimally Invasive Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia, characterized by loss of skeletal muscle mass and strength, is prevalent in patients undergoing treatment for colorectal cancer. Sarcopenia's prevalence in patients with cancer can reach up to 50% and is known to exacerbate postsurgical complications and affect long‐term oncological outcomes. This study examined whether minimally invasive surgery (MIS) offers protective benefits against postoperative sarcopenia compared with open surgery in patients undergoing rectal cancer resection.

Methods

This retrospective analysis included 145 patients who underwent open or minimally invasive (laparoscopic or robot‐assisted) rectal resections at the University Hospital Dresden between 2013 and 2021. Confounding variables were adjusted using propensity score matching. The skeletal muscle index (SMI) and psoas muscle thickness per height (PMTH) were analysed in preoperative and postoperative computed tomography scans to measure changes in skeletal muscle mass. Potential risk factors for muscle loss were evaluated, and oncological long‐term outcome was analysed.

Results

The results indicate that oncological rectal resection did not result in pronounced postoperative muscle loss. No significant difference between the open and MIS groups in terms of postoperative muscle loss over 3 years postoperatively could be detected. Wound healing disorders were identified as the most significant independent risk factors for muscle loss (SMI loss > 10%). In contrast, neither the type of surgical technique nor the presence of a protective loop ileostomy significantly influenced the development of postoperative muscle loss. Patients who experienced a > 10% SMI loss within the first year had significantly poorer overall and disease‐free survival. The 1‐year survival rate was 93.3% in the group with high SMI loss compared with 100.0% in the group with low SMI loss ( p = 0.435). The 3‐year (66.7% vs. 95.6%, HR 8.75, 95% CI 1.855–41.286, p = 0.006) and 5‐year (44.4% vs. 93.3%, HR 11.072, 95% CI 2.414–50.782, p = 0.002) survival rates were significantly lower in patients with high SMI loss. Patients with high SMI loss had an increased likelihood of recurrence and metastasis.

Conclusions

Although MIS did not confer a protective advantage against postoperative muscle loss in patients with rectal cancer, the findings highlight the critical role of maintaining muscle mass in improving survival outcomes. Postoperative muscle loss appears to be a marker of aggressive tumour behaviour, and interventions aimed at minimizing muscle loss, such as enhanced nutritional support, may improve the long‐term patient prognosis. Future studies should explore interventional strategies to mitigate sarcopenia in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaColorectal NeoplasmsMinimally Invasive Surgical ProceduresHumansMaleFemaleAgedMiddle AgedRetrospective StudiesPostoperative ComplicationsRisk FactorsAged, 80 and over

Stichwörter der Autor:innen

minimally invasive surgeryoncological outcomeopen surgeryrectal cancersarcopeniaskeletal muscle index

Autor:innen und Institutionen

  • Department of Visceral, Thoracic and Vascular Surgery, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
  • German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Institute and Polyclinic for Diagnostic and Interventional Radiology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • General, Visceral and Transplant Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.

ORCID-Profile: Felix Merboth

Zitieren

APA

Merboth, F., Müller-Oerlinghausen, M., Nebelung, H., Bogner, A., Pecqueux, M., Salisch, N., Distler, M., Plodeck, V., Hoffmann, R. T., Fritzmann, J., Weitz, J., & Kirchberg, J. (2025). Sarcopenia in Colorectal Cancer Surgery—Minimally Invasive vs. Open. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70065

Vancouver

Merboth F, Müller-Oerlinghausen M, Nebelung H, Bogner A, Pecqueux M, Salisch N, et al. Sarcopenia in Colorectal Cancer Surgery—Minimally Invasive vs. Open. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.70065

BibTeX
@article{Merboth2025,
  author = {Merboth, Felix and Müller-Oerlinghausen, Miriam and Nebelung, Heiner and Bogner, Andreas and Pecqueux, Mathieu and Salisch, Nadja and Distler, Marius and Plodeck, Verena and Hoffmann, Ralf-Thorsten and Fritzmann, Johannes and Weitz, Jürgen and Kirchberg, Johanna},
  title = {Sarcopenia in Colorectal Cancer Surgery—Minimally Invasive vs. Open},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.70065}
}
Kostenlos starten →